{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "2",
          "submission_status": "AP",
          "submission_status_date": "20251030",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "84029",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761322s002lbl.pdf",
              "date": "20251031",
              "type": "Label"
            },
            {
              "id": "84030",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/761322s002lbl.pdf#page=26",
              "date": "20251031",
              "type": "Medication Guide"
            },
            {
              "id": "84035",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/761322Orig1s002ltr.pdf",
              "date": "20251103",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20230824",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 2",
          "submission_class_code_description": "Type 2 - New Active Ingredient",
          "application_docs": [
            {
              "id": "75284",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761322s000lblcorrection.pdf",
              "date": "20230824",
              "type": "Label"
            },
            {
              "id": "75293",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/761322Orig1s000ltr.pdf",
              "date": "20231011",
              "type": "Letter"
            },
            {
              "id": "75705",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2023/761322Orig1s000TOC.html",
              "date": "20231011",
              "type": "Review"
            },
            {
              "id": "76274",
              "url": "https://www.accessdata.fda.gov/scripts/cder/rems/index.cfm?event=IndvRemsDetails.page&REMS=423",
              "date": "20231103",
              "type": "REMS"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20260202",
          "review_priority": "N/A",
          "submission_class_code": "REMS",
          "submission_class_code_description": "REMS"
        }
      ],
      "application_number": "BLA761322",
      "sponsor_name": "SANDOZ INC",
      "openfda": {
        "application_number": [
          "BLA761322"
        ],
        "brand_name": [
          "TYRUKO"
        ],
        "generic_name": [
          "NATALIZUMAB-SZTN"
        ],
        "manufacturer_name": [
          "Sandoz Inc"
        ],
        "product_ndc": [
          "61314-543"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "INTRAVENOUS"
        ],
        "substance_name": [
          "NATALIZUMAB"
        ],
        "rxcui": [
          "2725173",
          "2725180"
        ],
        "spl_id": [
          "29c4086f-ca52-4f83-9119-bada7ec65482"
        ],
        "spl_set_id": [
          "ef653c36-dd4b-4e71-9d2d-40b8fea24b67"
        ],
        "package_ndc": [
          "61314-543-94"
        ],
        "nui": [
          "N0000175775",
          "N0000175774"
        ],
        "pharm_class_epc": [
          "Integrin Receptor Antagonist [EPC]"
        ],
        "pharm_class_moa": [
          "Integrin Receptor Antagonists [MoA]"
        ],
        "unii": [
          "3JB47N2Q2P"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "No",
          "brand_name": "TYRUKO",
          "active_ingredients": [
            {
              "name": "NATALIZUMAB-SZTN",
              "strength": "300MG/15ML(20MG/ML)"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "INJECTABLE",
          "route": "INJECTION",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}